thiobenzyl benzyloxycarbonyl-l-lysinate has been researched along with chromozym th in 1 studies
| Studies (thiobenzyl benzyloxycarbonyl-l-lysinate) | Trials (thiobenzyl benzyloxycarbonyl-l-lysinate) | Recent Studies (post-2010) (thiobenzyl benzyloxycarbonyl-l-lysinate) | Studies (chromozym th) | Trials (chromozym th) | Recent Studies (post-2010) (chromozym th) |
|---|---|---|---|---|---|
| 9 | 0 | 0 | 45 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Machner, M; Prellwitz, W; Schmitt, KF; Schuster, CJ; Weilemann, L | 1 |
1 other study(ies) available for thiobenzyl benzyloxycarbonyl-l-lysinate and chromozym th
| Article | Year |
|---|---|
Two automated methods for plasma antithrombin III compared, and the clinical significance of the results.
Topics: Adolescent; Adult; Aged; Antithrombin III; Centrifugation; Chromogenic Compounds; Contraceptives, Oral; Disseminated Intravascular Coagulation; Female; Half-Life; Heparin; Humans; Lysine; Male; Middle Aged; Oligopeptides; Postoperative Period; Shock; Thromboembolism | 1982 |